文献库搜索 | GeneLibs

Van Nieuwenhuysen(E),Henry(S),Muylle(K),De... Acta Clin Belg 2026-04-00

...BRCA1/BRCA2 status was insufficiently characterized, likely reflecting the lack of perceived relevance of BRCA1/BRCA2 mu...

Joyce(CM),Bacal(J),Chowdhury(SP),Brown(AN)... Cell Rep 2026-01-27

...BRCA1 and BLM. Chromatin-loaded FANCD2-FANCI has a second, distinct function promoting a G2 cell cycle arrest that is de...

Pellisé-Tintoré(M),Gaillard(T),Laas(E),Fou... Surg Oncol 2026-02-00

...BRCA1 and BRCA2 mutations face a significantly increased lifetime risk of developing ovarian and fallopian tube cancer. ...

Dore(S),Sacchi(M),Pinna(A),Palmieri(G),Pal... Oncol Res None

...BRCA1 associated deubiquitinase 1 (BAP1), splicing factor 3b subunit 1 (SF3B1), and eukaryotic translation initiation fa...

Chudziak(AV),Morris(TJ),Maliy(D),Saglimben... Curr Issues Mol Biol 2026-01-16

...BRCA1, and STAT5B, underscoring the need for diverse representation in TC genomics. Notably, MTOR mutations were signifi...

Liu(Q),Fan(Y),Huang(C),Wu(M),Jin(Y),Tao(L)... ESMO Open 2026-02-00

...BRCA1/2-mutated epithelial ovarian cancer patients between 2015 and 2024. Patients who achieved complete or partial resp...

Rossouw(B),Araujo(M),Krause(A),Baine-Savan... Fam Cancer 2026-01-31

...BRCA1 and BRCA2 variants accounting for 20–55% of these cases, while other implicated genes include BRIP1, ATM, RAD51C, ...

Khatri(L),Fraker(J),Pruthi(S) Maturitas 2026-03-00

...BRCA1, CHEK2 and PALB2 variants confer lower risk. Males with breast cancer typically present with subareolar masses, ni...

Sherman(ME),Pacheco-Spann(L),Friedman(S),R... Gynecol Oncol 2026-03-00

To survey knowledge, preferred information sources, and risk tolerance for EC among BRCA1 and BRCA2 pathogenic variant (...

Bilen(MA),Shore(N),Burbage(S),Rossi(C),Dia... Urology 2026-05-00

...BRCA1/2) alterations were observed among 17.4% (12.7%) of White patients, 16.5% (10.9%) of non-White patients, and 15.2%...